Current and Future Immunotherapy Approaches for HCC: Evidence, Guidance, and Resources

Watch this on-demand Webcast featuring an expert presentation on the use of checkpoint inhibitors in patients with advanced hepatocellular carcinoma. This program specifically focuses on educating hepatologists, medical oncologists, and other members of the multidisciplinary care team.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 24, 2020 Expired: No longer available for credit

Overview of HCC and Key Considerations for Systemic Therapy

Immune Checkpoint Inhibitors in Contemporary Management of Advanced HCC

Practical Guidance for Using Immune Checkpoint Inhibitors

In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer audience questions focused on current best practices and emerging applications with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: January 21, 2021

In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, provide a succinct discussion of key considerations in the contemporary use of immune checkpoint inhibitors for treating patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: January 22, 2021

In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations for hepatologists, oncologists, and other HCPs in the contemporary use of immune checkpoint inhibitors for treating specific patient cases with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: May 17, 2021

In this downloadable PDF transcript from a CCO podcast, David Kaplan, MD, MSc, and Thomas Karasic, MD, discuss HCP questions focused on current best practices with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.

Download this slideset for multidisciplinary expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with advanced HCC.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: September 9, 2020

Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with HCC.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: September 14, 2020

Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer audience questions from a series of live CCO Webinars focused on current best practices and emerging applications with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 10, 2020 Expired: No longer available for credit

Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, as they provide a succinct discussion of key considerations in the contemporary use of immune checkpoint inhibitors for treating patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: January 19, 2021 Expired: No longer available for credit

Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations for hepatologists, oncologists, and other healthcare professionals in the contemporary use of immune checkpoint inhibitors for treating specific patient cases with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: May 17, 2021 Expired: No longer available for credit